Sagar Bio Tech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.50 Cr
as on 24-10-2024
- Revenue -2.14%
(FY 2023)
- Profit -70.53%
(FY 2023)
- Ebitda 0.58%
(FY 2023)
- Net Worth 9.99%
(FY 2023)
- Total Assets 8.23%
(FY 2023)
About Sagar Bio Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.50 Cr.
Chintan Patel, Mansukhbhai Patel, and Manishbhai Patel serve as directors at the Company.
- CIN/LLPIN
U01403GJ2010PTC062465
- Company No.
062465
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sagar Bio Tech Private Limited offer?
Sagar Bio Tech Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Flower Seeds, Mosquito & Insect Repellent, Insect Trap, Vegetable Seeds, Mosquito Repellent, Seeds, Fruit Seeds.
Who are the key members and board of directors at Sagar Bio Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintan Patel  | Director | 28-Sep-2010 | Current |
| Mansukhbhai Patel | Director | 28-Sep-2010 | Current |
| Manishbhai Patel | Director | 28-Sep-2010 | Current |
Financial Performance of Sagar Bio Tech.
Sagar Bio Tech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.14% decrease. The company also saw a substantial fall in profitability, with a 70.53% decrease in profit. The company's net worth moved up by a moderate rise of 9.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sagar Bio Tech?
In 2023, Sagar Bio Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gabani Brothers LimitedActive 2 years 7 monthsChintan Patel, Mansukhbhai Patel and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2022 | ₹1.80 Cr | Open |
Others Creation Date: 27 Jul 2022 | ₹2.50 Cr | Open |
Others Creation Date: 25 May 2021 | ₹1.20 Cr | Open |
How Many Employees Work at Sagar Bio Tech?
Unlock and access historical data on people associated with Sagar Bio Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagar Bio Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagar Bio Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
